Kalaora, S., Lee, J. S., Barnea, E., Levy, R., Greenberg, P., Alon, M., . . . Samuels, Y. (2020). Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma. Nature Portfolio.
Cita Chicago Style (17a ed.)Kalaora, Shelly, et al. Immunoproteasome Expression Is Associated with Better Prognosis and Response to Checkpoint Therapies in Melanoma. Nature Portfolio, 2020.
Cita MLA (8a ed.)Kalaora, Shelly, et al. Immunoproteasome Expression Is Associated with Better Prognosis and Response to Checkpoint Therapies in Melanoma. Nature Portfolio, 2020.
Precaución: Estas citas no son 100% exactas.